Our firm worked with industry leaders to establish the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), an association of research-based pharmaceutical companies that seeks to advance the science of orally-inhaled and nasal drug products by collecting and analyzing data and conducting joint research and development projects.
2022
Industry Leaders Establish International Pharmaceutical Aerosol Consortium on Regulation and Science
Lead Contacts
